Issues in the formulation of drugs for oral use in children: Role of excipients

Pediatric Drugs

Volumn 4, Issue 6, 2002, Pages 371-379

  Pawar, Shiwaji ^a   Kumar, Ashir ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ASPARTAME; AZO DYE; BICARBONATE; CALCIUM SALT; CARCINOGEN; CELLULOSE; CITRIC ACID; COLORING AGENT; CYCLAMATE SODIUM; ERYTHROSINE; EXCIPIENT; FLAVORING AGENT; FLUORESCEIN; GLUCOSE; GLYCEROL; INDOMETACIN; LACTOSE; MICROCRYSTALLINE CELLULOSE; POTASSIUM BICARBONATE; QUINOLINE DERIVATIVE; SACCHARIN; STARCH; SUCROSE; TARTRAZINE; THALIDOMIDE; TRIPHENYLMETHANE; UNINDEXED DRUG; XANTHENE DERIVATIVE;

ANGIONEUROTIC EDEMA; ANIMAL MODEL; BLADDER CANCER; BRONCHOSPASM; CHEMICAL CARCINOGENESIS; CHILD; CHILD HEALTH CARE; COLOR; CONTACT DERMATITIS; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; FLAVOR; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERACTIVITY; INFANT; LIQUID; MATERIALS; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SOLID;

EID: 0036083807     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200204060-00004     Document Type: Review

References (61)

1. Lack of pediatric formulations
2. Pharmaceutic factors affecting pediatrics compliance
3. Antibiotic prescribing practices and patient compliance in the community
4. Deaths due to elixir of sulfanilamide-massengill: Report of the Secretary of Agriculture submitted to house resolution 352 of November 19, 1937 and senate resolution of November 16, 1937
5. A study of German outbreak of phocomelia
6. Off-label uses of drugs in children
7. Survey of unlicensed and off label drug use in pediatric wards in European countries
8. Unlicensed and off label drugs use in pediatric wards: Prospective study
9. Off label and unlicensed drug use among French office based pediatricians
10. Adverse reaction to pharmaceutical excipients
11. Adverse effects of bulk materials
12. Sweeteners, flavoring and dyes in antibiotic preparations
13. The mystery ingredients: Sweeteners, flavorings, dyes and preservatives in analgesics/antipyretics, antihistamines/decongestant, cough and cold, antidiarrheal and liquid theophylline preparations
14. Sweeteners, dyes and other excipients in vitamin and mineral preparations
15. Formation of aflatoxin in different types of starches for pharmaceutical use
16. Toxicological evaluation of oxidized starch
17. The basic aspects of the chemical background of lactase deficiency
18. Health hazards of unlabeled ingredients in pharmaceuticals
19. When does lactose intolerance matter in adults
20. Progress report: New light on ethnic differences in adult lactose intolerance
21. Lactase deficiency in Mexican-American males
22. Lactase deficiency: A common genetic trait of the American Indian
23. Lactose intolerance in Jewish population
24. Lactose tolerance in an Arab population
25. Lactose filler as a cause of drug induced diarrhea
26. Small intestinal disaccharidase deficiencies
27. Lactose malabsorption and lactose intolerance
28. The clinical significance of lactose malabsorption
29. Outbreak of anticonvulsant intoxication in an Australian city
30. Enamel erosion with lemon juice
31. Copper deficiency associated with alkali therapy in a patient with renal tubular acidosis
32. Disulfiram treatment of alcoholism
33. Dental caries potential of liquid medications
34. Gastrointestinal irritant effect of glycerin as compared with sorbitol and propylene glycol in rats and dogs
35. Glycerol intolerance in child with intermittent hypoglycemia
36. Prospective study of cosmetic reactions, 1977-1980
37. The Saccharin question re-examined: An ADA statement
38. Sugar substitutes
39. How do we feed the persons with diabetes
40. Cyclamates antagonistic to antibiotic: JG Wagner reports that absorption of lincomycin hydrochloride drops 75% when present with sodium or calcium cyclamate [news]
41. Sweetener intakes
42. Artificial sweeteners and human bladder cancer: Preliminary results
43. Saccharin: Review of safety issues
44. Inactive ingredients in pharmaceutical products: Update
45. Calculation of aspartame intake in children
46. Aspartame as a dietary trigger of headache
47. Aspartame and susceptibility to headache
48. The effect of aspartame on migraine headache
49. Aspartame-induced granulomatous panniculitis
50. Aspartame: Possible effect on seizure susceptibility
51. Aspartame approved despite risks
52. Adverse reactions of aspirin and related drugs
53. An assessment of thimerosal use in childhood vaccines
54. Impact of the joint statement by the American Academy of Pediatrics/US public health service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices
55. Balancing risks and benefits: Primum non nocere is too simplistic
56. Inactive ingredients in pharmaceutical products
57. Allergy to so called "inert ingredients" (excipients) of pharmaceutical preparations